Amarin Raises Supply Issue Again On US Vascepa Generics

Originator Eschews 2021 Guidance Following Hikma Launch

Businessmen_Rocket
Amarin is confident Hikma and other ANDA sponsors will continue to lag behind on supply • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products